Literature DB >> 29246269

Adult-Onset Sleepwalking Secondary to Hyperthyroidism: Polygraphic Evidence.

Loretta Giuliano1, Daniela Fatuzzo1, Greta Mainieri1, Sandro La Vignera2, Vito Sofia1, Mario Zappia1.   

Abstract

ABSTRACT: Sleepwalking is a disorder characterized by complex motor behaviors arising from slow wave sleep usually occurring in children. The adult onset of sleepwalking suggests the presence of an external precipitating factor leading to the occurrence of the disorder. Hyperthyroidism has been reported to be the possible cause of sleepwalking in a few cases. We present the case of a 36-year-old man who reported a sudden appearance of nocturnal episodes of sleepwalking. He underwent a complete video polysomnography (VPSG), which showed a polygraphic pattern arising from stage N3 sleep related to the presence of simple motor behaviors. Routine blood tests showed a mild hyperthyroidism. After 4 months of thyrostatic treatment, the patient reported no more sleepwalking events. A VPSG performed at the last follow-up showed the absence of pathological electroclinical events arising from stage N3 sleep. Therefore, we hypothesize that there is a link between sleepwalking and thyroid dysfunction in our patient.
© 2018 American Academy of Sleep Medicine

Entities:  

Keywords:  hyperthyroidism; sleepwalking; video polysomnography

Mesh:

Year:  2018        PMID: 29246269      PMCID: PMC5786849          DOI: 10.5664/jcsm.6954

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  11 in total

1.  Sleep and wakefulness in somnambulism: a spectral analysis study.

Authors:  C Guilleminault; D Poyares; F A Aftab; L Palombini; F Abat
Journal:  J Psychosom Res       Date:  2001-08       Impact factor: 3.006

Review 2.  Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications.

Authors:  Mark R Pressman
Journal:  Sleep Med Rev       Date:  2007-02       Impact factor: 11.609

3.  Z drug zombies: parasomnia, drug effect or both?

Authors:  Nathaniel S Marshall; Peter R Buchanan
Journal:  Sleep Med Rev       Date:  2011-10       Impact factor: 11.609

4.  Alcohol and non-rapid eye movement parasomnias: where is the evidence?

Authors:  John M Rumbold; Renata L Riha; Ian Morrison
Journal:  J Clin Sleep Med       Date:  2014-03-15       Impact factor: 4.062

5.  Influence on sleep of hyperthyroidism.

Authors:  P Passouant; T Passouant-Fontaine; J Cadilhac
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1967-09

Review 6.  Primary sleep disorders in people with epilepsy: clinical questions and answers.

Authors:  Madeleine M Grigg-Damberger; Nancy Foldvary-Schaefer
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2014-10-03

7.  Sleepwalking associated with hyperthyroidism.

Authors:  Kamel M Ajlouni; Azmi T Ahmad; Mohamed M El-Zaheri; Mohammad M Al-Zahiri; Fawwaz L Ammari; Nadim S Jarrah; Mousa A AbuJbara; Heitham K Ajlouni; Tewfik K Daradkeh
Journal:  Endocr Pract       Date:  2005 Jan-Feb       Impact factor: 3.443

8.  HLA and genetic susceptibility to sleepwalking.

Authors:  M Lecendreux; C Bassetti; Y Dauvilliers; G Mayer; E Neidhart; M Tafti
Journal:  Mol Psychiatry       Date:  2003-01       Impact factor: 15.992

9.  Sleep in thyrotoxicosis.

Authors:  G R Sridhar; Venkata Putcha; G Lakshmi
Journal:  Indian J Endocrinol Metab       Date:  2011-01

10.  Effects of supraphysiological doses of levothyroxine on sleep in healthy subjects: a prospective polysomnography study.

Authors:  Susanne Kraemer; Heidi Danker-Hopfe; Maximilian Pilhatsch; Frederik Bes; Michael Bauer
Journal:  J Thyroid Res       Date:  2011-07-07
View more
  2 in total

1.  Dream enactment behavior: review for the clinician.

Authors:  Marc Baltzan; Chun Yao; Dorrie Rizzo; Ron Postuma
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 2.  Neurologic Manifestations of Systemic Disease: Sleep Disorders.

Authors:  Eric M Davis; Chintan Ramani; Mark Quigg
Journal:  Curr Treat Options Neurol       Date:  2020-08-06       Impact factor: 3.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.